Exploration of Predictive Biomarkers for Sudden Unexplained Cardiac Death in Nonelderly People: A Case-Control Study

Sakai Kentaro1, Iwadate Kimiharu, Matsumoto Sari

  • 1From the *Tokyo Medical Examiner's Office, Tokyo Metropolitan Government; and †Department of Forensic Medicine, Jikei University School of Medicine, Tokyo, Japan.

Insights

Sudden unexplained cardiac death (SUCD) is linked to elevated high-sensitivity C-reactive protein (hs-CRP) levels in individuals with epilepsy or psychiatric disorders. This biomarker may indicate cardiac function impairment prior to fatal events.

Area of Science:

  • Cardiology
  • Biomarkers
  • Sudden Cardiac Death

Background:

  • Sudden unexplained cardiac death (SUCD) can affect nonelderly individuals, including those with epilepsy or psychiatric disorders.
  • The association between heart failure biomarkers and SUCD in these populations requires further investigation.

Purpose of the Study:

  • To analyze the association between heart failure biomarkers and SUCD.
  • To investigate serum concentrations of N-terminal probrain natriuretic peptide, high-sensitivity C-reactive protein (hs-CRP), and tumor necrosis factor α in SUCD patients.

Main Methods:

  • Serum biomarker analysis in 57 nonelderly SUCD patients diagnosed via medicolegal autopsy.
  • Patients categorized into subgroups: epilepsy, psychiatric disorders, and no specific medical history.
  • Comparison of biomarker levels against control groups.

Main Results:

  • Significantly elevated serum hs-CRP levels were observed in SUCD patients with epilepsy (P = 0.01) and psychiatric disorders (P = 0.01) compared to controls.
  • Psychiatric patients with schizophrenia exhibited significantly higher hs-CRP levels than controls (P = 0.003) and other psychiatric conditions (P = 0.01).
  • N-terminal probrain natriuretic peptide and tumor necrosis factor α levels did not differ significantly between SUCD patients and controls.

Conclusions:

  • Elevated hs-CRP levels are associated with SUCD in nonelderly individuals with epilepsy or psychiatric disorders.
  • High hs-CRP may indicate potential cardiac function impairment preceding SUCD.
  • Further research is warranted to elucidate the role of hs-CRP in SUCD pathogenesis.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
942
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
622
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
309
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
540
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K